Skip to main content
. 2004 Jul 20;321(2):370–378. doi: 10.1016/j.bbrc.2004.06.155

Fig. 5.

Fig. 5

Comparison of binding modes of the cyclic urea-based HIV protease inhibitor (colored in orange) and its covalent analogue (colored in cornflower blue) to SARS 3CLpro active site. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this paper.)